Yanai Shlomo is a director of Amneal Pharmaceuticals Inc - Ordinary Shares.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Amneal Pharmaceuticals, Inc.
11 May 23
4
Philip Morris International Inc.
5 May 23
4
Amneal Pharmaceuticals, Inc.
10 May 22
4
Philip Morris International Inc.
6 May 22
4
W R GRACE & CO
22 Sep 21
4
W R GRACE & CO
12 May 21
4
Philip Morris International Inc.
7 May 21
3
Philip Morris International Inc.
7 May 21
4
Amneal Pharmaceuticals, Inc.
7 May 21
4
Amneal Pharmaceuticals, Inc.
18 Dec 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 May 23 | AMRX Amneal Pharmaceuticals Inc - Ordinary Shares | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 80,128 | 0.00 | 169,274 |
10 May 23 | AMRX Amneal Pharmaceuticals Inc - Ordinary Shares | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 80,128 | 0.00 | 0 |
9 May 23 | AMRX Amneal Pharmaceuticals Inc - Ordinary Shares | RSU Class A Common Stock | Grant | Acquire A | No | No | 0 | 76,453 | 0.00 | 76,453 |
3 May 23 | PM Philip Morris International | Common Stock | Grant | Acquire A | No | No | 96.58 | 1,812 | 175.00 k | 5,506 |